Texas: beyond a utopia, a reality

With the legislative session still in effect, Texas moves closer to the industry patients deserve. Some of the most anticipated changes are from Rep. Stephanie Klick’s House Bill 1805 and dispensary licensing. The bill aims to increase the allowed amount of THC in medical cannabis and add chronic pain to the list of accepted medical conditions, as well as expanding state coverage. What once seemed like a utopia is becoming closer to reality. For this reason, in this new edition of Cannabis World Journals, Ethan Russo, a well-known neurologist, researcher, and author with a focus on psychopharmacology and the endocannabinoid system, is featured as the person of the month. In the CannaGrow section, the varieties of cannabis that should be produced to offer therapeutic benefits to patients in Texas are analyzed. In CannaCountry, we will talk about the United States, its progress in legislation, and projections. In CannaLaw, some cannabis litigation and the two faces of the cannabis industry in Texas are discussed. The CannaTrade section talks about the transformation of the cannabis industry in Texas, and finally, in the CannaMed section, the medicinal properties of cannabis in the management of endometriosis are described.

The right reached to reality 

2023 is presented as the year of great changes worldwide for the cannabis industry. During the last five years we have observed the transformation that the laws have had to reflect the reality that patients acclaim. The state of Texas has not been the exception and in this next legislative session #88 the opportunity is presented for the right to reach reality. For this reason, in this new edition of Cannabis World Journals we have as a person of the month Mihaela Plesa, a legislative director in Austin who has worked with small businesses throughout Texas while maintaining her passion for politics by collaborating with various organizations such as the National Organization for Young Women (Young NOW) and the National Organization for the Reform of Marijuana Laws (NORML). The CannaGrow section lists the soil conditions for growing medical cannabis in Texas. At CannaCountry we will talk about the United States, its advances in legislation and projections. At CannaLaw we will look at some cannabis litigation, the Compassionate Use Act (Tim Timmons) and the bills on the horizon for the 88th legislative session in Texas. The CannaTrade section talks about how cannabis companies enter the world of activism and regulation and finally, the CannaMed section describes hemp in the food industry as an uncertain but promising development.

Texas is in the spotlight with possible changes coming for the state in its 88th legislative session. In 2015, the Compassionate Use Program was established to grant access to patients in need of medical cannabis. However, is it really a law that works for patients? In this edition we explore the current licenses held by the state, the opinions of businesses, doctors and individuals who are transforming the reality of the cannabis industry as well as the future changes that are anticipated for Texas.

Learn all about the current realities in Texas in our new edition.

Chronicles of an Emerging Industry
How do we define the plant nowadays? We see more laws in favor, more people joining legalization projects, more people informing themselves about the plant on the internet and leaving fear or taboo aside. We have government initiatives where prohibitionism changes for decriminalization and eventually decriminalization for regulation. For this reason, in this new edition of Cannabis World Journals we have as company of the month Texas Cannabis Clinic, a company with medical experts for the diagnosis and personalized treatment of patients with medical cannabis in Texas. In the CannaGrow section we name the innovative techniques in 2023 for large-scale cannabis cultivation. In CannaCountry we will talk about Luxembourg, its progress in legalization and projections. In CannaLaw we will see some cannabis litigation and Colombia's initiative for the legalization of cannabis for adult use. In the CannaTrade section we will talk about mergers and acquisitions in the cannabis market for 2023 and finally, in the CannaMed section we will describe the role of the EPS for the therapeutic care of patients with medical cannabis.

365 Blank Pages for Cannabis

2023 will undoubtedly bring new challenges in a globalized world where scientific and medical breakthroughs are becoming more widespread. With these 365 days also comes the promise of new bills, new jurisprudence, new social movements, new activists, and new voices seeking to rectify the myths created around the plant. For those many reasons, in this new edition of Cannabis World Journals, we have Lumír Ondřej Hanuš, a world-renowned analytical chemist and leading figure in cannabis research, as our Person of the Month. In the CannaGrow section, we look at cannabis crop investment options. In CannaCountry, we will discuss cannabis prohibitions and restrictions in two states in the USA: Texas vs. Illinois. In CannaLaw, we will see the new Initiative in Texas to decriminalize cannabis, the most relevant cases in Cannabis Litigation, and what is coming for Germany this new year. In the CannaTrade section, we talk about the trends in marketing in the cannabis industry. Finally, in the CannaMed section, we describe the role of medical cannabis in public health and how cannabis works in sports.

You've met him at the movies as a father, detective, friend, and villain; but did you know the side of him dedicated to cannabis? If you did not know this about him, then do not waste anymore time. Read this edition and discover why Jim Belushi is no longer just a movie character, because he has transcended the movie set and is creating a new universe of possibilities in the cannabis industry
 Jim Belushi, this award is yours: Person of the Year in the Cannabis Industry!

Texas: Cannabis Promised Land.

Without a doubt, this has been a year of growth and favorable changes for the cannabis industry. From the passing of beneficial laws to dispensaries opening, the plant has managed to thrive despite the obstacles it has faced, proving whoever perseveres wins. In this new edition of Cannabis World Journals, we have as our special guest Texas Cannabis Collective, a non-profit organization focused on news and events about the cannabis industry and laws in their state. The CannaGrow section examines how the FARM ACT favors Texas hemp production. CannaCountry compares legalization in Texas vs. California. In CannaLaw you will read about the most relevant cannabis litigation in 2022, as well as an analysis of how cannabis laws in the United States and in Texas influenced the most recent elections. The CannaTrade talks about how 2022 influenced the hemp industry in Texas. Finally, in the CannaMed, we describe the benefits that Texas has thanks to the prescription of medical cannabis and recount Alexis Bortell's story.

The Power Is in Texas.

Despite the restrictions that cannabis still has, the presence of the plant is becoming stronger worldwide. Such is the case of Texas in the United States, with thousands of opportunities to make it big in the cannabis industry. In this new edition of Cannabis World Journals, we have as special guests Jesce Horton, CEO of LOWD, an award-winning cannabis company, and the Texas Hemp Growers Association, one of the oldest hemp growers associations in Texas. The CannaGrow section discusses why hemp has more acceptance than psychoactive cannabis in the United States. CannaCountry details how Texas is not alone in having restrictions on cannabis use and possession in the United States. In CannaLaw, we look at the post-election direction of cannabis plant legality in Texas. In the CannaTrade section, we discuss the promising market for medical and industrial use of hemp in Texas. Finally, CannaMed looks at the Pro Nano Liposphere technology for CBD delivery and an opinion piece on the neglect of THC as a medical cannabinoid in Texas.

Cannabis: from Houston to the World.

In recent years, the cannabis industry has been on an upward trend, closely related to the rise of cannabis as a legislative and regulatory interest in many countries. As a result, investor attraction to this previously marginalized sector has increased. Cannabis, with its more than 10,000 different uses, is no longer a simple drug, but medicine and a potential market worth 37.4 billion dollars by 2021. In this new edition of Cannabis World Journals, we have as special guests the US Cannabis Council, one of the largest coalitions of cannabis companies, associations, and advocacy organizations. In  CannaGrow we discuss how algae help cannabis cultivation thanks to their biostimulant action. While  CannaCountry details the progress made so far in Texas. In CannaLaw we will look at the future of cannabis in the lone star state, nad Crystal Munoz litigation case, and the state's recent midterm elections. In CannaTrade we analyze how cannabis advertising dodges obstacles with creativity and ingenuity, as entrepreneurs look for the hidden emerald of the cannabis industry. Finally, CannaMed presents suppositories as the winning alternative to administering cannabis and the benefits of medical cannabis antitumor therapies.

The Superheroes of the Industry

When we think of the characters and activists who fight continously to give cannabis the recognition it deserves in society, we could imagine them as superheroes who fight every day to free the industry. In this new edition of Cannabis World Journals, we have as special guest Andrew DeAngelo, activist and co-founder of Harborside Health Center, one of the best-known cannabis companies in the United States. In the CannaGrow section, we discuss how hemp can be the superfood to achieve food sovereignty. In CannaCountry, we detail the progress made in Brazil in terms of its cannabis regulation, outlook, and projections. In CannaLaw, we look at the future of federal legalization of cannabis, and Colombia's recent approval of a plan to decriminalize adult-use and commercialization of the plant. While, in the CannaTrade section, we talk about three new technology business trends to look for in the future of the cannabis industry. Finally, our CannaMed section studies how medical cannabis helps treating fibromyalgia and the therapeutic potential of phytocannabinoids CBDV and THCV.

When has a war ever been easy?
Usually when something is worthwhile it always has a slow process, full of falls, learning, challenges, what we like to call “trial and error.” The legalization process of cannabis doesn’t escape this reality. For many years the warriors of the plant have given the best so that the chains of ignorance and misinformation are finally broken. For this reason, in this new edition of Cannabis World Journals we have as special guest Dr. Alonso Martínez, co-founder of IndicaMed in Ecuador, a network of health professionals linked to research that promotes an integrative model of care between evidence-based medicine and cannabinoid-based therapy. The CannaGrow section discusses how hemp cultivation can be applied as a soil phytoremediator. In CannaCountry we detail the progress made in New Zealand in terms of its regulation, landscape, and projections. In CannaLaw we will look at President Biden’s outlook towards federal legalization in the US, as well as analyzing adult-use cannabis in the Czech Republic. The CannaTrade section discusses the possibility of hemp as a replacement for cotton cultivation and how to navigate the maze of the U.S. cannabis industry. Finally, the CannaMed section looks at how medical cannabis helps in the treatment of Lupus and action against UV rays.

Hail to cannabis! Hail to life!

We live in a world full of possibilities. The legalization of cannabis is something “Inevitable.” So, sooner rather than later, it will happen, and, on that day, many patients, lawyers, growers, doctors, and investors will be, “stronger than ever” and will be able to say at the top of their lungs, Hail to Cannabis! For that reason, in this new edition of Cannabis World Journal we have as a special guest Ricky Williams owner of “Real Wellness,” a holistic brand and “Highsman,” a cannabis lifestyle brand with products personally selected to empower professional and amateur athletes. The CannaGrow section discusses how hemp cultivation can be applied to building harmonious spaces. In CannaCountry we detail the progress made in Panama in terms of its regulation, panorama and cannabis projections. In CannaLaw we will see the cannabis litigation in Mexico and its unconstitutional declaration for the prohibition of the personal use of cannabis, a chronicle on whether it is considered guilty to cultivate medical cannabis, as well as an analysis of Hong Kong in its backwardness in cannabis regulation. The CannaTrade section discusses the labor market and public health impact of the plant's legislation at the federal level and a comparative chart on the cannabis market and opioid production. Finally, the CannaMed section looks at how medical cannabis helps insomnia and the treatment of seizures.

Here's to cannabis!
Medical and scientific discoveries give more strength every day to the existing benefits offered by the cannabis plant, allowing advances in terms of its legislation and, in turn, offering the development of innovative cannabis companies. For this reason, in this new edition of Cannabis World Journal we have as a special guest Yotam Hod, Co-founder of GYNICA, a company immersed in cannabis and women's liberation. In the CannaGrow section, it is analyzed how hemp cultivation can achieve its objectives of reducing environmental impacts for adequate sustainable development. CannaCountry details the progress made in Chile in terms of cannabis regulation, panorama and projections. In CannaLaw we will see the cannabis litigation of New York Medical Cannabis Indus. Assoc, Inc. vs. New York State Department of Health and The Commonwealth v. Harrelson, in addition to analyzing the testimony of Alicia Mijares, a woman who uses medicinal cannabis and who must deal with stigma and taboo in Spain. The CannaTrade section talks about the importance of the existence of dispensaries for easy access to plant derivatives and how people have become interested in using cannabis to achieve general mental and physical well-being. Finally, in the CannaMed section, the phytocannabinoid CBC is studied as an ally for acute respiratory distress syndrome and the phytocannabinoid CBD for cardiovascular health.

Our homeland is cannabis
For years, efforts have been made to overcome the lack of knowledge and stigma about the cannabis plant, it has been difficult to understand that it is necessary to fight in order to defend noble causes that at the end of the day will only bring wellbeing and health. However, it is important to analyze and contemplate the following question: How much would be gained by breaking the chains that oppress cannabis? For this reason, Cannabis World Journal brings a new edition in which we have as special guest Matías Litvak, Co-founder of Mediplant Sj, Consultant at GrowForce and SCI in cannabis industry projects. In the CannaGrow section we analyze how terpenes in synergy with cannabinoids mean a greater efficacy to treat different progressive health conditions. In CannaCountry we detail the advances made in the United Kingdom in terms of its regulation, panorama, and cannabis projections. In CannaLaw we will see the cannabis litigation in the United States of America vs. Cannabis Cultivators Club and Dennis Peron, in addition to analyzing the reality of those who are currently deprived of their freedom because of cannabis. The CannaTrade section discusses the importance of the adult-use market, the synthetic cannabinoid market and the market for new medical cannabis users. Finally, in the CannaMed section, CBD is studied as an alternative therapy against salmonella spp and as an ally against inflammatory intestinal diseases.

By the gods, cannabis will have justice!

These are extremely important times for the cannabis industry. Although unfortunately it has not yet been legalized in several countries, many others have given the long awaited Yes to the change! Hoping in this way to grant the great and long-awaited justice to the plant. For this reason, in this new edition, we will have as special guests Jason Martin and Jason McKnight, creators of the brand “Coffee & Kush”, who visualize cannabis and music as a lifestyle of their own. The CannaGrow section will consider the case of Charlotte's Web and how the symbiosis between cannabis and fair regulation helped with her recovery. CannaCountry details the progress made in Australia in terms of its regulation, state landscape and cannabis projections. In CannaLaw we will look at the cannabis litigation of B. S. and C. A. vs. Public Prosecutor and the National Council of the Order of Pharmacists, we also evaluate the case of the Secretary of State for Justice and Security vs. E. P. and analyze the reality of those who are currently deprived of their liberty because of cannabis. The CannaTrade section discusses how the Juicy Fields platform situation affects the cannabis business, as well as the description of market opportunities and the main comparisons between the local and multinational market of the cannabis industry. Finally, the CannaMed section studies CBD as an alternative therapy for refractory epilepsy in children and for the control of diabetes mellitus.

Let's shout yes to the legalization of Cannabis

Taking into account the presence of cannabis in so many civilizations, from ancient times to the present day, it could be said that the plant is an immortal being that has embraced the world in all its stages, in order to establish its own rights and freedoms. For this reason, in this new edition, we will have as a special guest Congressman Earl Blumenauer, who has actively sought the end of the War on Cannabis. In the CannaGrow section we analyze how the self-cultivation of cannabis is the key to its own legislation. CannaCountry details the progress made in Spain in terms of regulation, beneficiaries, and upcoming cannabis legal measures. In CannaLaw we will see the cannabis litigation of Ultra Health Inc vs. Insurance Companies, Vincent Hager vs. M&K Construction and Canada as a reference country in the regulation of cannabis for medical and adult use. In the CannaTrade section we talk about tips for finding legal cannabis investors, ideas for entrepreneurship in the cannabis industry and developments in the US Congress vs. Biden. Finally, the CannaMed section discusses how cannabinoids help women's gynecological health and the thyroid gland.

Legalization forever and ever, amen.

Although the road that cannabis has had to travel under its legislation for years has not been easy, it has always had a light of hope, a shining light that has accompanied it in every period, in every moment and generation. In this new edition, we will have as special guest Brotsanber, a law firm from Spain. In the CannaGrow section, we will analyze the cultivation of medical and industrial cannabis around the world. In CannaCountry, we will detail the progress made in Portugal in terms of legalization and allowed uses for the cannabis industry. In CannaLaw, we will see the Carl Hamilton vs Foundation of cannabis litigation, as well as the advances in the legalization of the plant in Germany. In the CannaTrade section, we will talk about the legal cannabis business as a generator of employment and the prospects for cannabis growth in Thailand and Wall Street. Finally, the CannaMed section analyzes how cannabis can fight allergies and the methods and guidelines for its correct dosage.

The voice of emerald green

Despite adversity, cannabis has found a thousand ways to emerge like daisies in the snow on more than one occasion. It could be said that the plant has patiently traveled the yellow brick road to triumphantly enter the well-remembered Emerald City where it will shine in all its splendor. In this new edition, we will have as special guest Laganja Estranja, cannabis advocate and LGBTQ+ icon. The CannaGrow section analyzes how the cannabis plant is capable of bringing together the most diverse communities. In CannaCountry we detail the progress made in Thailand in terms of legalization, first steps and what is coming for this country in the cannabis industry. In CannaLaw we will see the cannabis litigation of Milena Pozo, as well as the progress in the legalization of the plant thanks to the LGBT+ movement. The CannaTrade section discusses the main cannabis brands and dispensaries belonging to the LGBTQ+ community with the logo "Cannabis Celebrates Diversity" and analyzes why the community is relevant to the cannabis industry. Finally, the CannaMed section discusses cannabis products for LGBTQ+ pride and how they help to reduce the asthma crisis among young people.

Towards the Cannabis Olympus

We are pleased to present the first anniversary of the Cannabis World Journals magazine, where we have the important task of going beyond the limits and comfort zone, to continue informing in an objective and responsible way to the general public about the "Divine Gifts" of the plant and thus, break the paradigms of fear and misinformation about the cannabis industry. Therefore, we will have as a special guest Anne Marie Graham, director of the digital magazine Cannabis World Journals, a leading media in cannabis information. The CannaGrow section analyzes the great leap of cannabis from the media. In CannaCountry we detail the progress made in Peru in terms of legalization, authorized uses, and production for specific purposes of cannabis. In CannaLaw we will see the cannabis litigation of the companies MedMen and Whitestar, as well as the advances in the legalization of the plant in countries such as Spain and Pakistan.  In the CannaTrade section we talk about the keys to the success of a cannabis business and economic alternatives such as cannabis tourism. Finally, in the CannaMed section you will learn how cannabis influences the treatment of HIV and as an alternative therapy for anxiety and stress disorders.

King Cannabis on Top of the World
For years, cannabis has been an example of struggle, empowerment, will, and progress. In this new edition, we will show how cannabis has benefited human beings from its origins to the present day. We have as a special guest Riley Cote, former hockey player and co-founder of Bodychek Wellness, a brand that specializes in CBD-based products. In CannaGrow, we observe how the first hemp crops give the current basis for implementing a sustainable and conservation system. In CannaCountry, we detail the progress made in northern Morocco in legalization, authorized uses, and production for specific purposes of cannabis. In CannaLaw, we analyze expectations surrounding Argentina after the approval of a law for using medical cannabis and the progress of the latest bill presented in the United States to lower taxes in the cannabis industry. In the CannaTrade section, we talk about the origin of the cannabis industry, and ask ourselves if the world is ready for a global cannabis economy. Finally, in the CannaMed section, we learn how cannabis has been used to treat migraines since time immemorial and the use of cannabinoids for glaucoma throughout history.

Cannabis: To Infinity and Beyond

Cannabis is probably the only medicinal plant that has contributed the most to improving the quality of life of millions of people. In this new edition, we present the voices of the cannabis industry and how they contribute to society. We have as a special guest Juan Camilo Castro, commercial manager of Aurora Medical Cannabis from Colombia, which is interested in helping treat chronic diseases through the use of CBD. In the CannaGrow section, we observe how cannabis is an industry of infinite possibilities and how it could lead the world economy. In CannaCountry, we detail the progress made in Mexico in terms of legalization, authorized uses, and cannabis production for specific purposes. The CannaTrade section discusses Hollywood as the HubSpot for all the cannabis celebrities and the emergence of leading entrepreneurs in the cannabis business. In CannaLaw, we take a look at the efforts made by Congresswoman Caterina Licatini on cannabis legislation in Italy, as well as the triumphant approval of the new regulatory framework for medical cannabis and industrial hemp in Argentina. Finally, in the CannaMed section, we learn about the main discoveries and findings of Dr. Raphael Mechoulam, the father of modern cannabis research. We also bring you a detailed review of the phytocannabinoid CBG for dermatological use.

Robin “Cannabis” Hood

Cannabis is the plant that, despite its stigmatization, has contributed the most to improving the quality of life of millions of people. With this edition we focus on how cannabis contributes to society. We have a very special guest: Jaleel White, actor, producer and screenwriter, who tells us all about his new brand of cannabis products and his experience as an entrepreneur. In the CannaGrow section we look at how the Cannabis industry is the force behind Canada's GDP and how hemp might replace some industries in the future. In CannaCountry we detail how Luxembourg has made progress in cannabis legalization. In the CannaTrade section we will look at the relationship of cannabis to sustainable economies and why it could be an important player. Finally, in the CannaMed section, we learn about the prospects for using cannabis-based medicines and how terpenes and flavonoids are used in a growing market.

Cannabis: Eden's Plant

In this edition, we will have a special guest: the company Jushi Holdings, an American company dedicated to the cultivation, processing, and distribution of cannabis products for medicinal and adult use. We will share more details about the Argentinean NGOs that now can grow cannabis and also about the Swiss legislation regarding the plant. In addition, in the CannaTrade section, we will talk about the profitability of hemp, its cultivation, and derivatives, and the path towards a sustainable cannabis industry. Finally, in the CannaMed section, we will discuss the medicinal properties of hemp seeds and the benefits of hemp on health and well-being.

No Fear for the Cannabis Cause: Leaders and Advocates

Cannabis World Journals presents in this 22nd edition different influential people in the world of cannabis, such as Mike Tyson, and their work in the fight to destigmatize this plant. This edition includes an interview with Thomas B. Kin Chong, a Canadian actor, comedian, musician, and activist.

The CannaLaw section mentions the legal progress of cannabis and its derivatives in different countries. CannaTrade features the leading products in the cannabis industry and a basic guide to investing in cannabis. In the CannaMed section, you will learn about the Cannahaler, which is revolutionizing cannabis inhalers; and an overview of the studies carried out by Cristina Sanchez analyzing cannabinoids in cellular energy metabolism and their behavior in the elimination of cancer cells.

Woman: Perfect Example of Power, Perseverance and Hard Work

In this edition dedicated to extolling the influence of women in the cannabis industry you can meet different women fighters who dedicate their lives and their knowledge in different areas so that cannabis is seen as a symbol of health and wellness around the world. There are exclusive interviews with some of them. In addition, in the CannaTrade section, the future outlook for the role of women in the cannabis industry is shown. And finally, the CannaMed section describes the relationship between women and cannabis medicine, and how cannabis is used in responsible motherhood.

Cannabis: A Right for Everyone?

On this occasion we will talk about the relationship of cannabis with laws, law and social justice. From the right to self-cultivation to the struggle to strip cannabis of its unjust criminalization. There is an exclusive interview with Kevin Smith, a filmmaker and staunch advocate of cannabis. In addition, in the CannaTrade section, the best ideas for getting started in the cannabis industry and how cannabis affects the global economy are discussed. Finally, in the CannaMed section, we analyze how the communication between patient and health professional affects the medicinal cannabis prescription process. Also, the different kinds of cannabis-based medicines available on the market.

Cannabis In the World's Spotlight

This edition mentions the growing interest of cannabis growers in hemp and the donation made by the NFL for $1 million USD to cannabis studies. Marihuana Televisión also participates with its coordinator Marcial Cervero and his team, who comment on their work and contribution to the industry as a media outlet. In the CannaLaw section, the immense progress that cannabis has had in Colombia and the steps that are being taken in Mississippi regarding its legalization. In the CannaMed section, we talk about the CBD and THC-based therapeutic alternative that cannabis offers for Alzheimer's disease and the use of medical cannabis in post-traumatic stress disorder. You will find these and more topics of interest in this issue of Cannabis World Journals.

Cannabis in the Hands of Atlas

This edition describes the various developments that the cannabis plant has had in the world, both in scientific discoveries and economic trends, and in addition to this, the importance of water quality in cannabis cultivation. There is a special guest who also shares his experience as an entrepreneur in the cannabis industry, Shavo Odadjian, the bassist of the band System Of A Down. In the CannaTrade section, we discuss the topic of cannabis in the metaverse and the possible repercussions of cannabis taxes on the industry as well. Finally, the CannaMed section reports on the recent discovery of acids present in the cannabis plant that can prevent the spread of COVID-19, and the use of cannabis for skin care.

Cannabis shines in the 2022 firmament

Today we tell you about the ongoing efforts in different parts of the world to decriminalize and legalize cannabis and the achievements that have been obtained. With a special guest appearance by NORML's Deputy Director, Paul Armentano, who told us about his experience as part of the change in the history of the cannabis industry.

In the CannaGrow section, the approach to cost-saving production of synthetic cannabinoids is discussed. In CannaTrade, new trends in the cannabis industry for 2022 are mentioned. To close, the CannaMed section explores the Cannabis Sativa plant and its non-THC components in-depth, and reports perceptions of patients regarding the therapeutic benefits of medical cannabis use.

War warned, victory assured

Cannabis World Journals presents in this sixteenth edition several initiatives that seek to advance the rights of responsible cannabis use in order to ensure justice for those who use or possess cannabis or some of its derivatives. This edition also includes a conversation between Steve De Angelo, the all-time cannabis entrepreneur, and the CWJ team, plus a description of the latest trends influencing and contributing to the cannabis industry. 

In the CannaGrow section, a description of diseases that can affect the cannabis plant is given; and in the CannaMed section, a clinical practice guideline regarding medical cannabis for chronic pain is granted. Finally, an overview of cannabis in the year 2021 is mentioned.

Volume No. 45 - May 2023

Volume No. 44 - April 2023

Volume No. 43 - March 2023

Volume No. 42 - February 2023

Volume No. 41 - January 2023

Volume 40 - December 2022

Volume 39 -  December 2022

Volume No 38 - December 2022

Volume  No 37 - November 2022

Volume No 36 - November 2022

Volume No 35 – October 2022

Volume No 34 – October 2022

Volume 33 - September 2022

Volume 32 – September 2022

Volume 31 - August 2022

Volume 30 - August 2022

Volume 29 - July 2022

Volume 28 - July 2022

Volume 27- June 2022

Volume 26 - June 2022

Volume 25 - Mayo 2022

Volume 24 - May 2022

Volume 23 - April 2022

Volume 22 - April 2022

Volume 21 - March 2022

Volume 20 - March 2022

Volume 19 - February 2022

Volume 18 - February 2022

Volume 17 - January 2022

Volume 16 - December 2021

Embark on a journey through the world of cannabis science, culture, and industry with Cannabis World Journals Magazine. We're thrilled to introduce you to this publication, your ultimate source for all things related to cannabis research, innovation, and the broader cultural impact of this fascinating plant. 

Cannabis World Journals Magazine, published by Cannabis World Journals, is not just a magazine; it's your comprehensive guide to the scientific, cultural, and industrial aspects of cannabis. As you explore the pages of Cannabis World Journals Magazine, you'll find a world of content that delves into the diverse facets of cannabis:

* Cannabis Science: Dive into the latest research, studies, and scientific breakthroughs in the field of cannabis. 
* Cultural Impact: Explore the broader cultural impact of cannabis, including its history, social influence, and evolving perceptions. 
* Industry Insights: Stay updated on the latest trends, innovations, and business developments in the cannabis industry. 
* Medical Cannabis: Learn about the medicinal applications of cannabis, including therapeutic uses and advancements in medical research. 
* Legislation and Advocacy: Stay informed about cannabis legislation, advocacy efforts, and the evolving legal landscape. 

Cannabis World Journals Magazine is your essential resource for navigating the science, culture, and industry of cannabis. Subscribe now and stay at the forefront of cannabis research, cultural dynamics, and industry trends.

1. Usted acepta que el uso de Magzter.com, la aplicación y sus servicios son bajo su propio riesgo. Ni Magzter.com ni sus asociados ni empleados ni proveedores de contenido de terceros garantizan que el servicio será completamente ininterrumpido o libre de errores o infalible contra actividades maliciosas. Tampoco garantizan que obtendrá los resultados exactos esperados o prometidos por el sitio web o el producto.

11. EL SERVICIO Y TODAS LAS PUBLICACIONES SE PROPORCIONAN 'TAL CUAL' Y 'SEGÚN DISPONIBILIDAD'. MAGZTER, SUS AFILIADOS, PROVEEDORES, LICENCIANTES Y AGENTES RENUNCIA EXPRESAMENTE A TODAS LAS GARANTÍAS DE CUALQUIER TIPO, YA SEA EXPLÍCITA O IMPLÍCITA, INCLUIDAS, ENTRE OTRAS, LAS GARANTÍAS IMPLÍCITAS DE COMERCIABILIDAD, IDONEIDAD PARA UN FIN DETERMINADO Y NO VIOLACIÓN. SIN LIMITAR LO ANTERIOR, NI MAGZTER NI SUS AFILIADOS, PROVEEDORES, LICENCIANTES O AGENTES OFRECEN NINGUNA GARANTÍA DE QUE (I) EL SERVICIO CUMPLIRÁ CON SUS REQUISITOS, (II) EL SERVICIO SERÁ ININTERRUMPIDO, PUNTUAL, SEGURO O LIBRE DE ERRORES, ( III) LA INFORMACIÓN QUE PUEDE OBTENERSE DEL USO DEL SERVICIO O QUE PUEDE ESTAR CONTENIDA EN LAS PUBLICACIONES SERÁ EXACTA O CONFIABLE, O (IV) LA CALIDAD DE CUALQUIER PUBLICACIÓN O DEL SERVICIO CUMPLIRÁ CON SUS EXPECTATIVAS. USTED ES EL ÚNICO RESPONSABLE DE OBTENER Y MANTENER UNA CONECTIVIDAD CONFIABLE A INTERNET Y SU DISPOSITIVO. MAGZTER NO ES RESPONSABLE DE SU INCAPACIDAD PARA DESCARGAR CONTENIDO. CUALQUIER MATERIAL DESCARGADO U OBTENIDO DE OTRO MODO A TRAVÉS DEL USO DEL SERVICIO SE REALIZA BAJO SU PROPIA DISCRECIÓN Y RIESGO Y USTED SERÁ EL ÚNICO RESPONSABLE DE CUALQUIER DAÑO A SU SISTEMA INFORMÁTICO O DISPOSITIVO MÓVIL O PÉRDIDA DE DATOS QUE RESULTE DE LA DESCARGA DE DICHO MATERIAL. NINGÚN CONSEJO O INFORMACIÓN, YA SEA ORAL O ESCRITO, OBTENIDO POR USTED DE MAGZTER O A TRAVÉS DEL SERVICIO CREARÁ NINGUNA GARANTÍA.

2. Mantendrá y actualizará de inmediato esa información para mantenerla verdadera, precisa, actual y completa. Usted es responsable de mantener la confidencialidad de su cuenta y contraseña y de restringir el acceso a su computadora, y acepta aceptar la responsabilidad de todas las actividades que ocurran en su cuenta, incluida la selección y el uso de todo el contenido y los servicios.

3. En ningún caso Magzter.com o cualquier persona o entidad o tercero involucrado en la creación, producción y distribución del contenido en el sitio web y la aplicación será responsable por contrato o legalmente por cualquier daño, incluidos, entre otros, directos, indirectos, incidentales, especiales y consecuentes incurridos por usted durante o al usar Magzter.com. Al registrarse en el sitio web o descargar la aplicación, acepta que las disposiciones mencionadas en esta sección se aplicarán a todo uso y contenido del sitio web y la aplicación.

3. Sin el permiso previo por escrito o autorizado de Magzter, no debe modificar, copiar, distribuir ni vender ningún contenido obtenido de Magzter, ya que todo lo publicado aquí es propiedad exclusiva de Magzter o sus licenciantes. Dado que dicho uso no autorizado también puede violar las leyes aplicables, incluidas las leyes de derechos de autor y marcas registradas, Magzter las prohíbe estrictamente y cancelará su acceso y su cuenta si se prueba o detecta dicha actividad ilegal. También debe ser responsable de los daños causados por estas actividades no autorizadas. Salvo que lo permita el propietario legítimo de la Publicación, usted reconoce que no adquiere ningún derecho de propiedad al descargar las Publicaciones a las que accede a través del Servicio. Salvo que lo exija explícitamente la ley de derechos de autor o lo permitan las características del Servicio, no puede modificar, aplicar ingeniería inversa, publicar, transmitir, exhibir, participar en la transferencia o venta, crear obras derivadas de, o de ninguna manera explotar comercialmente o proporcionar a un tercero el contenido de la Aplicación, las Publicaciones o cualquier parte de ellas sin el permiso expreso de Magzter y el propietario de dicho contenido. No le otorgamos ninguna licencia, expresa o implícita, de la propiedad intelectual de Magzter o de los licenciantes de Magzter.

5. Usted reconoce específicamente que Magzter.com no es responsable de ningún tipo de conducta difamatoria, ofensiva o ilegal de otros usuarios o terceros o su contenido y que el riesgo de lesión por lo anterior recae completamente en usted.

8. Magzter se reserva todos los derechos de monitorear el contenido publicado e ingresado por usted con el fin de determinar si cumple con estos términos y condiciones y otras reglas operativas determinadas por Magzter. Magzter tiene derecho a tomar decisiones sobre los contenidos y eliminarlos a su propia voluntad.

9. Magzter es un distribuidor y NO un editor de las Publicaciones, por lo que Magzter no tiene control editorial sobre el contenido, incluidas opiniones, consejos, declaraciones, servicios, ofertas, etc., que se representa en las revistas. Por lo tanto, Magzter no asumirá responsabilidad por la exactitud o confiabilidad de cualquier información o hecho proporcionado en el mismo o que esté disponible a través del servicio, por cualquier persona que no sea empleados autorizados de Magzter que estén actuando en sus capacidades oficiales. En consecuencia, no tenemos control editorial sobre las Publicaciones. Cualquier opinión, consejo, declaración, servicio, oferta u otra información o contenido expresado o puesto a disposición por terceros, incluidos los realizados en las Publicaciones ofrecidas por el Servicio, son de los respectivos autores o editores y no de Magzter. Magzter no será responsable de ninguna pérdida o daño causado por su confianza en la información obtenida a través del Servicio o de las Publicaciones. El Servicio puede contener enlaces a otros sitios de Internet y recursos de terceros y Magzter no asume ninguna responsabilidad por las comunicaciones o materiales disponibles en dichos sitios vinculados. Estos enlaces se proporcionan únicamente para su comodidad. Usted es el único responsable de comprender los términos y condiciones que puedan aplicarse cuando visita o realiza un pedido a través de un sitio de terceros.

El acceso, la navegación y el uso del sitio web de Magzter, los servicios de Internet y las aplicaciones para dispositivos móviles ('Aplicación') están sujetos a los siguientes Términos y condiciones ('Términos'). Por favor, lea estos Términos detenidamente. Crear una cuenta con Magzter ('nosotros', 'nosotros') o usar cualquier servicio o aplicación de Magzter o relacionado con Magzter significará que ha leído, entendido y acepta estar sujeto a estos Términos y cumplir con todas las leyes aplicables y reglamentos Estos Términos constituyen un acuerdo vinculante entre usted y Magzter Inc. y sus afiliados. Si no está de acuerdo con estos Términos, no puede usar el Servicio. ESTOS TÉRMINOS CONTIENEN RENUNCIAS DE GARANTÍA Y OTRAS DISPOSICIONES QUE LIMITAN LA RESPONSABILIDAD DE MAGZTER, POR LO QUE POR FAVOR LEA ESTOS TÉRMINOS EN SU TOTALIDAD. Magzter se reserva el derecho de cancelar inmediatamente su acceso al sitio web, servicio o aplicación relacionada con Magzter, si no cumple con este acuerdo. El sitio web de Magzter, los servicios de Internet y las aplicaciones para dispositivos móviles constituyen colectivamente el 'Servicio'. Este Servicio es propiedad y está operado por Magzter Inc. El Servicio incluye el sitio web www.magzter.com y la aplicación que le brinda la capacidad de ordenar, suscribirse y recibir la entrega de varias revistas, libros, noticias y contenido relacionado con revistas y publicaciones. (conocidos colectivamente como 'Publicaciones') y recibir estas versiones digitales de las Publicaciones.

 Detalles del contenido objetable, incluido su enlace en nuestra plataforma

 Descarga tus títulos favoritos y léelos sin conexión, en cualquier momento y en cualquier lugar

 Regale a sus seres queridos una tarjeta de regalo de Magzter al instante y déles la libertad de leer sus revistas y periódicos favoritos de miles de títulos más vendidos.

Gift your loved ones with a Magzter Gift Card instantly and give them the freedom to read their favorite magazines from thousands of best-selling titles.

Regara a tus seres queridos una Tarjeta de regalo de Magzter y dales la libertad de leer sus revistas favoritas entre {{magCount}} títulos internacionales de mayor venta.

Girish Ramdas es cofundador y director ejecutivo de Magzter, una empresa nueva con sede en Nueva York que ha estado causando sensación en el negocio editorial digital mundial. Magzter ha superado los 80 millones de usuarios desde su creación en 2011 de más de 150 países con miles de revistas, periódicos y libros de más de 4500 editoriales de todo el mundo. Tiene más de 25 años de experiencia en publicación multiplataforma, incluido el desarrollo web, móvil y impreso. Durante este período, cofundó y dirigió tres exitosas empresas emergentes. Ha permitido que las empresas de revistas se vuelvan digitales y las ayuda a monetizar su contenido en todo el mundo digital. La profunda experiencia de Girish en la industria en ecosistemas en línea, móviles y editoriales lo ha convertido en un experto en adquisición, mercadeo y monetización de contenido digital en plataformas a nivel mundial.

 En caso de que encuentre algún contenido objetable en nuestra plataforma, hemos implementado una política de reparación de quejas para abordar sus inquietudes.

Magzter Inc. (”Compañía” , ”nosotros” , ”nos”  o ”nuestro” ) sabe que le importa cómo se usa y comparte su información personal.Lea la siguiente política de privacidad(la ”Política” ) para obtener más información sobre nuestras prácticas de privacidad.Al visitar cualquiera de los sitios web operados por la Compañía y cualquiera de sus subdominios, o al usar cualquiera de nuestras aplicaciones móviles y otros métodos de distribución de contenido(colectivamente, el ”Servicio” ), usted reconoce que acepta las prácticas y políticas descritas.en esta Política, y usted acepta que recopilaremos, usaremos y compartiremos su información de las siguientes maneras.

Magzter Inc. es el puesto de periódicos digital multiplataforma de autoservicio más grande y de más rápido crecimiento del mundo con más de 80 millones de usuarios desde su creación en 2011 y miles de revistas y periódicos en más de 40 categorías y más de 60 idiomas. Con sede en Nueva York, Magzter tiene presencia local en Ámsterdam, Londres, Ciudad de México, Chennai, Mumbai, Nueva Delhi, Bangalore, Singapur y pronto se expandirá a otros países. Fundada por los empresarios globales, Girish Ramdas y Vijay Radhakrishnan en junio de 2011, Magzter permite a los editores de revistas y periódicos de todo el mundo crear y entregar ediciones digitales de sus títulos a los consumidores globales.

 Magzter se compromete a proporcionar una plataforma segura para nuestros usuarios. Tenga en cuenta que Magzter es simplemente una plataforma para que los editores distribuyan su contenido. No controlamos ni respaldamos el contenido publicado en nuestra plataforma. No podemos responsabilizarnos por las acciones de nuestros editores o su contenido.

Magzter no es responsable de indemnizar a ninguna parte que haya sufrido daños o incurrido en costos debido a cualquier contenido, o parte del contenido, que viole sus derechos. Magzter no es responsable de enfrentar ninguna acción legal en un tribunal civil por cualquier violación de derechos causada por cualquier contenido, o parte del contenido, que infrinja los derechos de un tercero.

Magzter ofrece el servicio de suscripción ”All- You - Can - Read”  más grande del mundo llamado Magzter GOLD, que brinda a los lectores digitales acceso ilimitado a más de 8500 revistas y periódicos por un precio de suscripción mensual.Magzter también tiene la mayor cantidad de historias en el mundo con su innovadora función ezRead 2.0 para sus aplicaciones, que permite a los usuarios de teléfonos inteligentes y dispositivos móviles de pantalla pequeña disfrutar el contenido de la revista de la manera en que debe disfrutarse, con el texto del artículo que es fácil de leer y se acompaña de impresionantes videos y fotografías de alta resolución.

Nombre

Llena este formulario si necesitas ayuda para publicar tu contenido en Magzter

 Antes de Magzter, fue presidente de Dot Com Infoway (DCI) y Galatta Media. Sus funciones incluían marketing estratégico, desarrollo de asociaciones y monetización de contenido a nivel mundial. DCI creció de un pequeño equipo de 3 en 2000 a 300 en 2011 y se ocupaba del desarrollo web, de software y de aplicaciones para clientes de todo el mundo.

Desde que iniciamos, Magzter ha estado comprometida para asociarse con organizaciones globales para brindar la mayor tecnología y servicio de puesto de revistas posible a nuestros clientes. Si estás buscando ofrecer suscripciones a revistas a tu base de datos de clientes o si solo quieres aprender más, Magzter está comprometida a ayudar al crecimiento de tu empresa. Para obtener más información, llena el siguiente cuestionario:

 La DMCA nos permite restaurar el contenido eliminado si la parte que presentó el Aviso de DMCA original no presenta una acción judicial en su contra dentro de los diez días hábiles posteriores a la recepción de la copia de su Contraaviso.

Esta Política cubre el tratamiento de la Compañía de la información de identificación personal(”Información personal”) y otra información sobre usted y su computadora o dispositivo que la Compañía recopila cuando accede al Servicio.Podemos recopilar Información personal de usted, como se explica con más detalle a continuación, y usamos esta Información personal internamente en relación con nuestros Servicios, incluso para personalizar, proporcionar y mejorar nuestros productos, servicios, contenido y publicidad, y para permitirle para configurar una cuenta y un perfil de usuario, para contactarlo, para cumplir con sus solicitudes de ciertos productos y servicios, y para analizar cómo usa los Servicios.En ciertos casos, también podemos compartir cierta información personal con terceros, pero solo como se describe en el punto 4.

Este título está incluido con su suscripción Magzter GOLD

 Para analizar la calidad del contenido y proporcionar comentarios apropiados a los editores.

 Hemos designado un oficial de quejas para abordar cualquier queja relacionada con contenido objetable.

 Solicitamos que cualquier queja relacionada con contenido objetable se envíe al Oficial de quejas por correo electrónico a la dirección de correo electrónico mencionada anteriormente. También le solicitamos que proporcione los siguientes detalles al presentar una queja

y la Aplicación que le brinda la capacidad de ordenar, suscribirse y recibir la entrega de varias revistas, libros, noticias y contenido relacionado con revistas y publicaciones (conocidos colectivamente como "Publicaciones") y recibir estas versiones digitales de las Publicaciones

C.También recopilamos información asociada con su uso de la aplicación para hacer recomendaciones personalizadas.Si nos proporciona las credenciales de su cuenta de terceros, comprende que parte del contenido o la información de esas cuentas(”Información de la cuenta de terceros”) se puede transmitir a su cuenta con nosotros si autoriza dichas transmisiones, y esa cuenta de terceros La información transmitida al Servicio está cubierta por esta Política.

 F. La información personal que recopilamos nos permite responder a sus solicitudes, mejorar nuestros productos y servicios, personalizar la publicidad y el contenido que ve y comunicarnos con usted sobre nuevos productos.

es el puesto de periódicos digital multiplataforma de autoservicio más grande y de más rápido crecimiento del mundo con más de 85 millones de usuarios desde su creación en 2011 y miles de revistas y periódicos en más de 40 categorías y más de 60 idiomas. Con sede en Nueva York, Magzter tiene presencia local en Ámsterdam, Londres, Ciudad de México, Chennai, Mumbai, Nueva Delhi, Bangalore, Singapur y pronto se expandirá a otros países. Fundada por los empresarios globales, Girish Ramdas y Vijay Radhakrishnan en junio de 2011, Magzter permite a los editores de revistas y periódicos de todo el mundo crear y entregar ediciones digitales de sus títulos a los consumidores globales.

 norte. También utilizaremos la información de uso para garantizar que los usuarios cumplan con nuestros Términos de uso. Por ejemplo, la información de uso de un usuario nos ayudará a confirmar que un usuario solo descarga una revista u otro contenido un número permitido de veces o en un número permitido de dispositivos.

 que brinda a los lectores digitales acceso ilimitado a más de 8500 revistas y periódicos por un precio de suscripción mensual. Magzter también tiene la mayor cantidad de historias en el mundo con su innovadora función ezRead 2.0 para sus aplicaciones, que permite a los usuarios de teléfonos inteligentes y dispositivos móviles de pantalla pequeña disfrutar el contenido de la revista de la manera en que debe disfrutarse, con el texto del artículo que es fácil de leer y se acompaña de impresionantes videos y fotografías de alta resolución.

Cannabis World Journals- All Issues